Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1991 Jul 1;174(1):15–19. doi: 10.1084/jem.174.1.15

A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules

PMCID: PMC2118870  PMID: 1905337

Abstract

Recently, independent lines of evidence strongly suggested that peptides derived from one foreign major histocompatibility complex (MHC) molecule bound to another MHC molecule can give rise to multiple composite MHC complexes that are able to stimulate allo-(xeno)-reactive T cells. In this study, we describe that in vivo immunization of mice with cells mismatched with the recipient for a single class I antigen results in the induction of CD8+ cytotoxic T lymphocytes (CTL) specific for allogeneic class I locus products (Dd, Kd, Dq) in the context of other class I molecules (Ks, Kd, Kk) present on stimulator cells. Evidently, the target antigen for these class I-restricted alloreactive CTL is not the native class I molecule but peptides derived from endogenous processing of allogeneic class I products presented by class I molecules. Using a combination of limiting dilution and split-well analyses, we estimated for Kk-restricted Dq-specific alloreactive CTL a precursor frequency (CTLpf) that was approximately 10 times lower than the CTLpf for "classical" nonrestricted Dq-specific alloreactive CTL. These data suggest that H-2 class I peptides presented by intact H-2 class I molecules are allostimulatory, supporting the concept that the capacity for presentation of MHC peptides by MHC molecules constitutes a part of the allogeneic immune response.

Full Text

The Full Text of this article is available as a PDF (445.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achour A., Begue B., Gomard E., Paul P., Sayagh B., Van Pel A., Levy J. P. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes. Eur J Immunol. 1986 Jun;16(6):597–604. doi: 10.1002/eji.1830160603. [DOI] [PubMed] [Google Scholar]
  2. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature. 1987 Oct 8;329(6139):512–518. doi: 10.1038/329512a0. [DOI] [PubMed] [Google Scholar]
  3. Brown J. H., Jardetzky T., Saper M. A., Samraoui B., Bjorkman P. J., Wiley D. C. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature. 1988 Apr 28;332(6167):845–850. doi: 10.1038/332845a0. [DOI] [PubMed] [Google Scholar]
  4. Clayberger C., Parham P., Rothbard J., Ludwig D. S., Schoolnik G. K., Krensky A. M. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature. 1987 Dec 24;330(6150):763–765. doi: 10.1038/330763a0. [DOI] [PubMed] [Google Scholar]
  5. Demotz S., Grey H. M., Sette A. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science. 1990 Aug 31;249(4972):1028–1030. doi: 10.1126/science.2118680. [DOI] [PubMed] [Google Scholar]
  6. Essaket S., Fabron J., de Preval C., Thomsen M. Corecognition of HLA-A1 and HLA-DPw3 by a human CD4+ alloreactive T lymphocyte clone. J Exp Med. 1990 Jul 1;172(1):387–390. doi: 10.1084/jem.172.1.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harding C. V., Unanue E. R. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature. 1990 Aug 9;346(6284):574–576. doi: 10.1038/346574a0. [DOI] [PubMed] [Google Scholar]
  8. Heath W. R., Vitiello A., Sherman L. A. Mapping of epitopes recognized by alloreactive cytotoxic T lymphocytes using inhibition by MHC peptides. J Immunol. 1989 Sep 1;143(5):1441–1446. [PubMed] [Google Scholar]
  9. Holterman M. J., Engelhard V. H. HLA antigens expressed on murine cells are preferentially recognized by murine cytotoxic T cells in the context of the H-2 major histocompatibility complex. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9699–9703. doi: 10.1073/pnas.83.24.9699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Janeway C. A. Autoimmune disease: immunotherapy by peptides? Nature. 1989 Oct 12;341(6242):482–483. doi: 10.1038/341482a0. [DOI] [PubMed] [Google Scholar]
  11. Kievits F., Boerenkamp W. J., Lokhorst W., Ivanyi P. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition. J Immunol. 1990 Jun 15;144(12):4513–4519. [PubMed] [Google Scholar]
  12. Kievits F., Wijffels J., Lokhorst W., Ivanyi P. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice. Proc Natl Acad Sci U S A. 1989 Jan;86(2):617–620. doi: 10.1073/pnas.86.2.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kourilsky P., Claverie J. M. MHC-antigen interaction: what does the T cell receptor see? Adv Immunol. 1989;45:107–193. doi: 10.1016/s0065-2776(08)60693-8. [DOI] [PubMed] [Google Scholar]
  14. Maryanski J. L., Accolla R. S., Jordan B. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells. J Immunol. 1986 Jun 15;136(12):4340–4347. [PubMed] [Google Scholar]
  15. Maryanski J. L., Pala P., Cerottini J. C., Corradin G. Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA. J Exp Med. 1988 Apr 1;167(4):1391–1405. doi: 10.1084/jem.167.4.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Maryanski J. L., Pala P., Corradin G., Jordan B. R., Cerottini J. C. H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature. 1986 Dec 11;324(6097):578–579. doi: 10.1038/324578a0. [DOI] [PubMed] [Google Scholar]
  17. Ozato K., Hansen T. H., Sachs D. H. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol. 1980 Dec;125(6):2473–2477. [PubMed] [Google Scholar]
  18. Ozato K., Mayer N., Sachs D. H. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol. 1980 Feb;124(2):533–540. [PubMed] [Google Scholar]
  19. Parham P., Clayberger C., Zorn S. L., Ludwig D. S., Schoolnik G. K., Krensky A. M. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature. 1987 Feb 12;325(6105):625–628. doi: 10.1038/325625a0. [DOI] [PubMed] [Google Scholar]
  20. Schendel D. J. On the peptide model of allorecognition: cytotoxic T lymphocytes recognize an alloantigen encoded by two HLA-linked genes. Hum Immunol. 1990 Mar;27(3):229–239. doi: 10.1016/0198-8859(90)90053-r. [DOI] [PubMed] [Google Scholar]
  21. Song E. S., Linsk R., Olson C. A., McMillan M., Goodenow R. S. Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule. Proc Natl Acad Sci U S A. 1988 Mar;85(6):1927–1931. doi: 10.1073/pnas.85.6.1927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Strijbosch L. W., Buurman W. A., Does R. J., Zinken P. H., Groenewegen G. Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods. 1987 Feb 26;97(1):133–140. doi: 10.1016/0022-1759(87)90115-3. [DOI] [PubMed] [Google Scholar]
  23. Townsend A. R., Gotch F. M., Davey J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell. 1985 Sep;42(2):457–467. doi: 10.1016/0092-8674(85)90103-5. [DOI] [PubMed] [Google Scholar]
  24. Townsend A. R., Rothbard J., Gotch F. M., Bahadur G., Wraith D., McMichael A. J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 1986 Mar 28;44(6):959–968. doi: 10.1016/0092-8674(86)90019-x. [DOI] [PubMed] [Google Scholar]
  25. de Koster H. S., Anderson D. C., Termijtelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med. 1989 Mar 1;169(3):1191–1196. doi: 10.1084/jem.169.3.1191. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES